<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>registeration_number</th>
      <th>name</th>
      <th>establied_date</th>
      <th>country</th>
      <th>number_of_employes</th>
      <th>purpose</th>
      <th>phone_number</th>
      <th>email</th>
      <th>questura_country</th>
      <th>bankruptcy</th>
      <th>inscred</th>
      <th>fraudis</th>
      <th>investegation</th>
      <th>accused</th>
      <th>condamned</th>
      <th>civ_pass</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>4</th>
      <td>27ce7b74-7d6a-4d13-b91e-814f61dd179d</td>
      <td>ABB Ltd.</td>
      <td>8/20/1984</td>
      <td>Switzerland</td>
      <td>39</td>
      <td>prototype</td>
      <td>688-160-3651</td>
      <td>marketing@abbltd.org</td>
      <td>Lithuania</td>
      <td>False</td>
      <td>$28,186,488,620.00</td>
      <td>False</td>
      <td>True</td>
      <td>False</td>
      <td>False</td>
      <td>False</td>
    </tr>
    <tr>
      <th>29</th>
      <td>02895057-1d61-4576-a475-9e9ad28024d4</td>
      <td>ID Biomedical Corp.</td>
      <td>10/9/1996</td>
      <td>Canada</td>
      <td>19</td>
      <td>prototype</td>
      <td>118-870-8437</td>
      <td>marketing@idbiomedicalcorp.org</td>
      <td>Lithuania</td>
      <td>True</td>
      <td>$90,292,726,560.00</td>
      <td>False</td>
      <td>False</td>
      <td>True</td>
      <td>False</td>
      <td>False</td>
    </tr>
    <tr>
      <th>38</th>
      <td>2d3d1c8b-3cc1-4850-a919-ba4d6cb09075</td>
      <td>Tele Sudeste Celular Participacoes S.A.</td>
      <td>3/4/1976</td>
      <td>Brazil</td>
      <td>7</td>
      <td>prototype</td>
      <td>978-489-1684</td>
      <td>contact@telesudestecelularparticipacoessa.org</td>
      <td>Lithuania</td>
      <td>False</td>
      <td>$49,859,852,925.00</td>
      <td>False</td>
      <td>True</td>
      <td>False</td>
      <td>True</td>
      <td>False</td>
    </tr>
  </tbody>
</table>